Cost-benefit management decisions for carcinoma of the retromolar trigone

✍ Scribed by Dr. Michael G. Glenn; Dr. Arnold Komisar; Dr. George E. Laramore

• Publisher: John Wiley and Sons
• Year: 1995
• Tongue: English
• Weight: 606 KB
• Volume: 17
• Category: Article
• ISSN: 1043-3074
• DOI: 10.1002/hed.2880170511

✦ Synopsis

T h e patient is a healthy 60-year-old who has a 40-pack-year history of smoking and has had no prior treatment. Physical examination reveals a 3-cm lesion occupying the retromolar trigone and tonsillar fossa without extension to the maxillary tuberosity.

In your discussion of the issues please indicate your opinion regarding appropriate management if there is: 0 No bone destruction demonstrated by imaging. 0 Definitive bone destruction of the mandible by 0 No evidence of lymph nodes in the neck. 0 A clearly positive lymph node 3 cm in size in zone II of the ipsilateral neck. Include the following: 0 Treatment plan: Indicate whether you favor primary irradiation, primary surgery, combined radiation and surgery, or organ preservation with chemoradiation. 0 Repair: If surgery is advised, how would you reconstruct this lesion given a healthy patient From the University of Washington, Otolaryngology-Head and Neck Surgery. Sealtle. WA (Drs. Glenn and Laramore); and Lenox Hill Hospital, Cornell University Medical College, Otolaryngology-Head and Neck Surgery. New York. NY (Dr. Komisar).